Deheng Chen
Impact in
-
- Spine and Intervertebral Disc Pathology
- Spinal Cord Injury Research
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- Natural product bioactivities and synthesis 2
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- NF-κB Signaling Pathways 2
- Co-authors
- Xiaolei Zhang (8 shared papers)Xiangyang Wang (6 shared papers)Huazi Xu (6 shared papers)Naifeng Tian (5 shared papers)Yifei Zhou (4 shared papers)Ningyu Cai (3 shared papers)Kailiang Zhou (3 shared papers)Qian Tang (3 shared papers)
- Journals
- EBioMedicine (2 papers)European Journal of Medicinal Chemistry (1 paper)Scientific Reports (1 paper)iScience (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Deheng Chen
26 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 95
- Pathology and Forensic Medicine 381
- Cancer Research 216
- Pharmacology 237
- Rheumatology 165
- Molecular Biology 541
Countries citing papers authored by Deheng Chen
This map shows the geographic impact of Deheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deheng Chen more than expected).
Fields of papers citing papers by Deheng Chen
This network shows the impact of papers produced by Deheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deheng Chen. The network helps show where Deheng Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Deheng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 272 | |
| 2 | 2019 | 110 | |
| 3 | 2018 | 82 | |
| 4 | 2018 | 81 | |
| 5 | 2015 | 77 | |
| 6 | 2017 | 76 | |
| 7 | 2016 | 67 | |
| 8 | 2021 | 54 | |
| 9 | 2019 | 45 | |
| 10 | 2015 | 45 | |
| 11 | 2016 | 37 | |
| 12 | 2017 | 33 | |
| 13 | 2019 | 32 | |
| 14 | 2014 | 27 | |
| 15 | 2017 | 24 | |
| 16 | 2016 | 22 | |
| 17 | 2016 | 16 | |
| 18 | 2020 | 10 | |
| 19 | 2024 | 9 | |
| 20 | 2014 | 8 |
About Deheng Chen
Deheng Chen is a scholar working on Molecular Biology, Cancer Research, Surgery, Rheumatology and Pathology and Forensic Medicine, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (4 papers), Cancer-related molecular mechanisms research (4 papers), Spinal Cord Injury Research (4 papers), MicroRNA in disease regulation (3 papers), Inflammatory mediators and NSAID effects (3 papers), Natural product bioactivities and synthesis (2 papers), Pain Mechanisms and Treatments (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (381 citations), Cancer Research (216 citations), Pharmacology (237 citations), Rheumatology (165 citations) and Molecular Biology (541 citations). Deheng Chen has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Xiaolei Zhang, Xiangyang Wang, Huazi Xu, Naifeng Tian, Yifei Zhou, Ningyu Cai, Kailiang Zhou, Qian Tang, Daoliang Xu and Zongyou Pan. Their work appears in journals such as EBioMedicine, European Journal of Medicinal Chemistry, Scientific Reports, iScience and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.